
The offerings included schemes to promote the manufacturing of bulk drugs and medical devices such as Production Linked Incentive schemes and Promotion of Bulk Drug/Medical Devices Parks. It is estimated that Japanese companies would make the investment to the tune of Rs. 2,200 Crore in this sector.
A webinar on ‘Medical Devices and API sector: Challenges & Emerging Opportunities’ was recently held for promoting business and trade collaboration between India and Japan in the post-COVID-19 scenario. Read more...
Comments
Post a Comment